G
Glenn Barnes
Researcher at Millennium Pharmaceuticals
Publications - 6
Citations - 6239
Glenn Barnes is an academic researcher from Millennium Pharmaceuticals. The author has contributed to research in topics: Insulin resistance & Gene. The author has an hindex of 5, co-authored 6 publications receiving 5939 citations.
Papers
More filters
Journal ArticleDOI
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.
Haiyan Xu,Glenn Barnes,Qing Yang,Guo Tan,Daseng Yang,Chieh J. Chou,Jason Sole,Andrew Nichols,Jeffrey S. Ross,Louis A. Tartaglia,Hong Chen +10 more
TL;DR: It is proposed that obesity-related insulin resistance is, at least in part, a chronic inflammatory disease initiated in adipose tissue, and that macrophage-related inflammatory activities may contribute to the pathogenesis of obesity-induced insulin resistance.
Journal ArticleDOI
Fine-scale mapping of a locus for severe bipolar mood disorder on chromosome 18p11.3 in the Costa Rican population
L. Alison McInnes,Victor I. Reus,Glenn Barnes,Olga Charlat,Satya Jawahar,Steve Lewitzky,Qing Yang,Quyen Duong,Mitzi Spesny,Carmen Araya,Xinia Araya,Alvaro Gallegos,Luis Meza,Julio Molina,Rolando Ramirez,Roxana Mendez,Sandra Silva,Eduardo Fournier,Steven L. Batki,Carol A. Mathews,Thomas C. Neylan,Charles E. Glatt,Michael Escamilla,David Luo,Paresh Gajiwala,Terry Song,Stephen Crook,Jasmine B. Nguyen,Erin A. Roche,Joanne M. Meyer,Pedro León,Lodewijk A. Sandkuijl,Nelson B. Freimer,Hong Chen +33 more
TL;DR: The results suggest a candidate region containing six genes but also highlight the complexities of LD mapping of common disorders, as well as evaluation of haplotypes in pedigree CR001.
Patent
Methods and compositions for use of inflammatory proteins in the diagnosis and treatment of metabolic disorders
Haiyan Xu,Hong Chen,Glenn Barnes +2 more
TL;DR: In this article, the authors present methods and compositions for the diagnosis and treatment of metabolic disorders including, but not limited to, obesity, diabetes, and overweight insulin resistance, and also provide methods for identifying a compound capable of modulating a metabolic activity.
Patent
Compositions and methods for the diagnosis and treatment of neuropsychiatric disorders, including schizophrenia
TL;DR: In this article, a method and compositions for diagnosing and treating neuropsychiatric disorders, such as schizophrenia, schizoaffective disorder, bipolar affective disorder, unipolar affective disorders and adolescent conduct disorder, are presented.
Patent
Detection of polymorphisms in the human 5-lipoxygenase gene
Glenn Barnes,Joanne M. Meyer +1 more
TL;DR: In this article, the discovery of polymorphisms within the 5-lipoxygenase gene which are included in a haplotype is described, and a method for identifying specific alleles of polymorphic regions of a 5-LO gene, which can be used to determine whether a patient has a more or less severe phenotype of an inflammatory disease or disorder such as asthma.